Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lutrepatch
- Development stage
- Phase 2
- Lead developer
- Ferring Pharmaceuticals
- Modality
- Peptides, Drug Delivery Systems
- Administration
- Transdermal
01
Overview
Lutrepatch is an iontophoretic patch delivery system for gonadotropin-releasing hormone (GnRH) developed for treating female infertility. The patch uses iontophoretic technology to deliver pulsatile GnRH through the skin, which helps induce ovulation in women with anovulatory/oligoovulatory infertility. This delivery method allows for controlled administration of the hormone without requiring injections.
- Brand names
- Lutrepatch
- Other names
- GnRHSmart PatchGonadotropin-releasing hormone
02
Targets
GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on Lutrepatch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lutrepatch.